N.M.J. Rupniak

8.6k citations

111 papers · 5.5k indexed · h-index 43

Cellular and Molecular Neuroscience top 0.2%
- Neuropeptides and Animal Physiology 44
- Neuroscience and Neuropharmacology Research 33
- Neurotransmitter Receptor Influence on Behavior 28
Behavioral Neuroscience top 1%
Biological Psychiatry top 2%
Neurology top 1%
- Parkinson's Disease Mechanisms and Treatments 9
Psychiatry and Mental health top 2%
Molecular Biology
- Receptor Mechanisms and Signaling 43
- Pharmacological Receptor Mechanisms and Effects 12
Physiology
- Pain Mechanisms and Treatments 18
Cognitive Neuroscience
- Memory and Neural Mechanisms 11

Co-authors: C. D. Marsden Susan D. Iversen Peter Jenner Mark S. Kramer M. J. Steventon Angela Williams J.K. Webb S. Boyce
Cited by: Cellular and Molecular Neuroscience Behavioral Neuroscience Biological Psychiatry
Journals: Psychopharmacology (11 papers)Neuropharmacology (8 papers)European Journal of Pharmacology (7 papers)
Partner nations: United Kingdom United States Spain

In The Last Decade

N.M.J. Rupniak

110 papers receiving 5.3k citations

Peers

Countries citing papers authored by N.M.J. Rupniak

Since Specialization

Citations

This map shows the geographic impact of N.M.J. Rupniak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N.M.J. Rupniak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N.M.J. Rupniak more than expected).

Fields of papers citing papers by N.M.J. Rupniak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N.M.J. Rupniak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N.M.J. Rupniak. The network helps show where N.M.J. Rupniak may publish in the future.

Co-authorship network

The 25 scholars most cited alongside N.M.J. Rupniak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with N.M.J. Rupniak Line = papers co-authored together N.M.J. Rupniak links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Effect of GR205171 on autonomic dysreflexia induced by colorectal distension in spinal cord injured rats Spinal Cord ·N.M.J. Rupniak,Arno Wuenschmann,Shaoping Hou,Karl B. Thor,Lesley Marson	2023	1
2	The Hypothalamic–Pituitary–Adrenal Axis and Serotonin Metabolism in Individual Brain Nuclei of Mice with Genetic Disruption of the NK1 Receptor Exposed to Acute Stress Cellular and Molecular Neurobiology ·Juraj Čulman,J. Schwendeman,Annegret Blume,Jürgen Hedderich,Ulf Lützen,Stephen P. Hunt,N.M.J. Rupniak,Yi Zhao	2018	1
3	NK2 and NK1 receptor-mediated effects of NKA and analogs on colon, bladder, and arterial pressure in anesthetized dogs Naunyn-Schmiedeberg s Archives of Pharmacology ·N.M.J. Rupniak,Mary A. Katofiasc,Lesley Marson,Karl B. Thor	2017	11
4	Fused bicyclic pyrrolizinones as new scaffolds for human NK1 antagonists Bioorganic & Medicinal Chemistry ·Gregori J. Morriello,Robert J. DeVita,Sander G. Mills,Jonathan R. Young,Peter Lin,George A. Doss,Gary G. Chicchi,Julie A. DeMartino,Marc M. Kurtz,Kwei‐Lan Tsao,Emma Carlson,Rosalinda González-Santos,Alan Wheeldon,Susan Boyce,Neil Collinson,N.M.J. Rupniak,Stephen Moore	2007	24
5	Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression Neuropharmacology ·Martin R. Guscott,Linda J. Bristow,Karen L. Hadingham,T.W. Rosahl,Margaret S. Beer,Josephine A. Stanton,Frances A. Bromidge,Andrew P. Owens,Ian T. Huscroft,Yasser Saber,N.M.J. Rupniak,Shil Patel,Paul J. Whiting,Peter H. Hutson,K.C.F. Fone,Stephany M. Biello,Janusz J. Kulagowski,George McAllister	2005	184
6	Chronic substance P (NK1) receptor antagonist and conventional antidepressant treatment increases burst firing of monoamine neurones in the locus coeruleus Neuroscience ·Karen Maubach,Karine Martin,Gary G. Chicchi,Timothy Harrison,Alan Wheeldon,Christopher J. Swain,M. Cumberbatch,N.M.J. Rupniak,Guy R. Seabrook	2002	60
7	Anxiolytic actions of the substance P (NK1) receptor antagonist L-760735 and the 5-HT1A agonist 8-OH-DPAT in the social interaction test in gerbils Brain Research ·Survjit Cheeta,Sonia Tucci,Rajasekaran Mayuram Govindarajan,Angela Williams,N.M.J. Rupniak,Sandra E. File	2001	66
8	Intra-amygdala injection of the substance P (NK1 receptor) antagonist L-760735 inhibits neonatal vocalisations in guinea-pigs Neuropharmacology ·S. Boyce,David W. Smith,Emma Carlson,Louise Hewson,Michael Rigby,Ruth O’Donnell,Tim Harrison,N.M.J. Rupniak	2001	60
9	Analgesic and toxic effects of ABT-594 resemble epibatidine and nicotine in rats Pain ·S. Boyce,J.K. Webb,Sara L. Shepheard,Michael G. N. Russell,Reginald Hill,N.M.J. Rupniak	2000	39
10	Onset and Progression of Motor Deficits in Motor Neuron Degeneration (mnd) Mice Are Unaltered by the Glycine/NMDA Receptor Antagonist L-701,324 or the MAO-B Inhibitorr(−)-Deprenyl Experimental Neurology ·S. Boyce,J.K. Webb,Emma Carlson,N.M.J. Rupniak,R.G. Hill,JE Martin	1999	13
11	Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn Neuropharmacology ·S. Boyce,A. C. Wyatt,J.K. Webb,Ruth O’Donnell,G.S. Mason,Michael Rigby,Jason C. Dreabit,Reginald Hill,N.M.J. Rupniak	1999	283
12	The substance P antagonist L-760,735 inhibits stress-induced NK1 receptor internalisation in the basolateral amygdala Brain Research ·David W. Smith,Louise Hewson,Peter J. Fuller,Angela Williams,Alan Wheeldon,N.M.J. Rupniak	1999	67
13	Enantioselective inhibition of the formalin paw late phase by the NK1 receptor antagonist L-733,060 in gerbils Pain ·N.M.J. Rupniak,Emma Carlson,Susan Boyce,J.K. Webb,R.G. Hill	1996	69
14	Comparison of the effects of selective and nonselective muscarinic agonists on cognition and thermoregulation in primates Journal of the Neurological Sciences ·N.M.J. Rupniak,Spencer J. Tye,Susan D. Iversen	1992	18
15	Psychomotor activity and cognitive disruption attributable to NMDA, but not sigma, interactions in primates Behavioural Brain Research ·S. Boyce,N.M.J. Rupniak,M. J. Steventon,G.P. Cook,Susan D. Iversen	1991	37
16	Characterisation of dyskinesias induced byl-dopa in MPTP-treated squirrel monkeys Psychopharmacology ·S. Boyce,N.M.J. Rupniak,M. J. Steventon,Susan D. Iversen	1990	47
17	Nigrostriatal Damage is Required for Induction of Dyskinesias by l-DOPA in Squirrel Monkeys Clinical Neuropharmacology ·S. Boyce,N.M.J. Rupniak,M. J. Steventon,Susan D. Iversen	1990	90
18	Drug-induced purposeless chewing: animal model of dyskinesia or nausea? Psychopharmacology ·N.M.J. Rupniak,Spencer J. Tye,Susan D. Iversen	1990	9
19	Antiparkinsonian efficacy of a novel transdermal delivery system for (+)-PHNO in MPTP-treated squirrel monkeys Neurology ·N.M.J. Rupniak,Spencer J. Tye,C.A. Jennings,Alice E. Loper,Joseph V. Bondi,M Hichens,Elizabeth Hand,Susan D. Iversen,Stephen M. Stahl	1989	27
20	Elevation of circulating prolactin concentrations may not cause striatal dopamine receptor supersensitivity European Journal of Pharmacology ·N.M.J. Rupniak,Giuseppe Bucci,S. Mansfield,Simon Fleminger,R.G. Dyer,Peter Jenner,C. D. Marsden	1983	14

About N.M.J. Rupniak

N.M.J. Rupniak is a scholar working on Cellular and Molecular Neuroscience, Behavioral Neuroscience, Physiology, Molecular Biology and Neurology, having authored 111 papers that have together received 5.5k indexed citations. Recurring topics across this work include Neuropeptides and Animal Physiology (44 papers), Receptor Mechanisms and Signaling (43 papers), Neuroscience and Neuropharmacology Research (33 papers), Neurotransmitter Receptor Influence on Behavior (28 papers), Pain Mechanisms and Treatments (18 papers), Pharmacological Receptor Mechanisms and Effects (12 papers), Memory and Neural Mechanisms (11 papers) and Parkinson's Disease Mechanisms and Treatments (9 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (3.7k citations), Behavioral Neuroscience (530 citations), Biological Psychiatry (212 citations), Neurology (773 citations) and Psychiatry and Mental health (568 citations). N.M.J. Rupniak has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include C. D. Marsden, Susan D. Iversen, Peter Jenner, Mark S. Kramer, Peter Jenner, M. J. Steventon, Angela Williams, J.K. Webb, S. Boyce and Emma Carlson. Their work appears in journals such as Psychopharmacology, Neuropharmacology, European Journal of Pharmacology, Clinical Neuropharmacology and Bioorganic & Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact